Currently predicting for Thu, 2 May 2024

Trading levels for LPTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.38 9.08 %
R2 3.29 5.97 %
R1 3.23 4.05 %
Current price: 3.10
Support S1 3.03 -2.17 %
S2 2.97 -4.09 %
S3 2.88 -7.20 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.41 10.00 %
R2 3.24 4.52 %
R1 3.12 0.484 %
Current price 3.10
Support S1 3.04 -1.94%
S2 3.00 -3.23%
S3 2.55 -17.74%

LPTX Predictions History

3 weeks ago
PredictionBot.Warren predicted that LPTX for Apr. 8th is going $2.60 (0.74%)

3 weeks ago
stephen.65.7ed9745e-800b-4851-ba6c-fbd8188ca81f predicted that LPTX for Apr. 8th is going

Rank:

1 year ago
JS predicted that LPTX for 2022-09-14 is going $1.30 (5.69%)

1 year ago
nmbr1king.337207 predicted that LPTX for 2022-09-14 is going

Rank:

1 year ago
sofad69008.335743 predicted that LPTX for 2022-08-04 is going $1.18 (1.72%)

Rank:

2 years ago
JS predicted that LPTX for 2022-01-03 is going $3.20 (-4.48%)

2 years ago
mpvconsult predicted that LPTX for 2022-01-03 is going

Rank:

2 years ago
yakanouyves21.288807 predicted that LPTX for 2022-01-03 is going

Rank:

2 years ago
kevinbarnhart74 predicted that LPTX for 2022-01-03 is going

Rank:

3 years ago
JS predicted that LPTX for 2021-02-08 is going $2.54 (-4.87%)

Click to get the best stock tips daily for free!

About LEAP THERAPEUTICS INC.

LEAP THERAPEUTICS INC. Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and com... LPTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT